Fast start key as Hampshire hangs on for win against DeKalb

SHARE Fast start key as Hampshire hangs on for win against DeKalb

HAMPSHIRE 35, DEKALB 34

THE SKINNY: Hampshire held on for a 35-34 victory over DeKalb (1-1) Friday night in Hampshire. The Whip-Purs got off to a quick start scoring on their first two possessions and outgaining the Barbs 147 to 1 in the first quarter.

TURNING POINT:After DeKalb got to within two points late in the third quarter, Hampshire (2-0) answered with a 15-play, 75-yard drive that took 7:32 off the clock. Quarterback Nick Mohlman capped the drive off with a 13-yard touchdown pass to Tim Jansen.

THE STAR:Hampshire senior running back Nick Kielbasa rushed for 177 yards on 32 carries and scored two touchdowns .

BY THE NUMBERS: Nick Mohlman was 10-of-11 for 153 yards and two touchdowns. Jansen finished with five catches for 102 yards and two touchdowns.

QUOTABLE: “This was a great victory for our team against a good DeKalb team”, said Jansen. “That drive late in the third quarter was huge for us. I have such a good relationship on the field with Nick (Mohlman). He just gives me a look and I know where to go to get the ball.”

The Latest
Girls says the man is angry that she stood up for her mom in a disagreement about the couple’s sex and drinking habits.
Trout Unlimited’s Trout In The Classroom teaches young students about fish and the aquatic environment, capped by a day trip to get all wet.
From endorsing a new Bears’ stadium to revoking the subminimum wage, Johnson’s critics and allies examine where he and the city are going.
Businesses and neighborhood associations in River North and nearby want the city to end the dining program because of traffic congestion, delays to first responders and other headaches caused by closing off a major street artery, a local restaurant executive writes.
High doses become routine patient care even when they make patients so ill that they skip doses or stop taking the drugs. “There’s a gap in FDA’s authority that results in patients getting excess doses of a drug at excess costs,” says Dr. Mark Ratain, a University of Chicago oncologist.